Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04963153 |
Title | Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Los Angeles General Medical Center | RECRUITING | Los Angeles | California | 90033 | United States | Details |
USC / Norris Comprehensive Cancer Center | RECRUITING | Los Angeles | California | 90033 | United States | Details |
UCHealth University of Colorado Hospital | SUSPENDED | Aurora | Colorado | 80045 | United States | Details |
Moffitt Cancer Center | RECRUITING | Tampa | Florida | 33612 | United States | Details |
Ohio State University Comprehensive Cancer Center | SUSPENDED | Columbus | Ohio | 43210 | United States | Details |
University of Pittsburgh Cancer Institute (UPCI) | RECRUITING | Pittsburgh | Pennsylvania | 15232 | United States | Details |
UT Southwestern/Simmons Cancer Center-Dallas | RECRUITING | Dallas | Texas | 75390 | United States | Details |
Huntsman Cancer Institute/University of Utah | SUSPENDED | Salt Lake City | Utah | 84112 | United States | Details |
University Health Network-Princess Margaret Hospital | RECRUITING | Toronto | Ontario | M5G 2M9 | Canada | Details |